Generating Evidence for Optimal Market Access: An Executive Interview with Jeff Anderson and Rosemary Jose, OPEN Health
Jeff Anderson is CEO of the Evidence & Access practice and Rosemary Jose leads Strategic Market Access strategy and activities. [...]
ISPOR General Business Meeting to Take Place on May 26th
ISPOR will hold a virtual General Business Meeting on May 26th from 9:00 AM to 9:45 AM EDT. The session [...]
New Webinar on RWE and Clinical Trials Now Available
HealthVerity is offering a new webinar on understanding the value of RWE (real world evidence). In addition to reducing the [...]
Revealing the Unknown: How the COVID Active Research Experience (CARE) Registry is Enhancing Community Health
Since COVID-19 first emerged as a global pandemic, the pharmaceutical industry has risen to meet the virus' related challenges from a prevention as well as a treatment perspective.
RWE Provides Architecture for Healthcare Decisions
The many types of data resulting from RWE (real world evidence) provide substantial information for healthcare institutions, regulators, and pharmaceutical companies, [...]
Redbird RWE Develops System Making RWE Regulations More Navigable
Too much precious time is lost trying to navigate the complex and often convoluted landscape of real world evidence regulations. [...]
Racial Biases Persist in Widely-used Analytics Software
According to a recent article published by Casey Ross of Stat News, infusion of bias into decisions about who should [...]
Real-world Data Takes Center Stage in COVID-19 Response: Evidence Accelerator Community Tool Featured in Webinar by DIA
A webinar on "Real-World Data to Inform COVID-19 Response: Collaborating in the COVID-19 Evidence Accelerator" is taking place on Tuesday, [...]
Former FDA Commish Califf: Weighing the Benefits & Risks of the Growing Number of Observational Treatment Assessments
In a recently published JAMA Viewpoint, former FDA Commissioner Robert Califf and colleagues mused about a growing concern about inferring [...]
IQVIA’s Dreyer Stresses Importance of RWE Amid Pandemic
In a recent interview with Managed Healthcare Executive, IQVIA CSO Nancy Dreyer said the COVID-19 pandemic has made the use [...]
Taking Action from RWE Analytics: Use of Health Insights Dataset Reveal Underdiagnosis and Care Gaps in NASH and NAFLD
Excerpt of tHEORetically Speaking blog post sponsored by Veradigm Nonalcoholic fatty liver disease (NAFLD), including the more aggressive NASH (nonalcoholic [...]
McClellan Stresses Need for RWE Infrastructure
Duke-Margolis' Mark McClellan tells The Pink Sheet a robust real-world evidence infrastructure is needed, and that RWE studies should be [...]
Researchers Support Targeted Population Health Interventions to Boost COVID-19 Outcomes
Health care systems should target population health interventions to patients with existing chronic diseases to bolster COVID-19 outcomes, researchers in [...]
Pink Sheet Analysis Spotlights COVID-19 Article Debacle
A recent analysis by the Pink Sheet looks at how the retraction of Lancet and New England Journal of Medicine [...]
Using AI, NLP and Data Visualization with RWE to Generate Insights into Care Gaps: Retrospective Cohort Analysis of Fracture Risk in Patients with Osteopenia and Osteoporosis
This blog reports practical uses of RWD sourced from the largest, cloud-based electronic health record (EHR) platform in the United States, offered by Veradigm® as part of its Health Insights database.
RCTs vs. RWE? Why Not Both?
Aetion Co-Founder and President Jeremy Rassen in a recent blog post discusses a new paradigm in which randomized controlled trials [...]
Former FDA Chiefs Encourage Collection of RWE
Former Food and Drug Administration chiefs Mark McClellan and Scott Gottlieb urged greater incentives for the collection of real-world evidence [...]
Prieto-Alhambra Talks RWE in Decision-Making During Pandemic
University of Oxford's Daniel Prieto-Alhambra in a recent interview with The Evidence Base discussed the role of real-world evidence amid [...]
Evidera Blog Post Highlights Approach to Assessing Real-World Research Questions
A recent Evidera blog post highlights its systematic approach to the assessment of real-world research questions supported by digital enablement. [...]
Collecting Data in the Midst of a Pandemic
Evidera's Mariah Baltezegar in a recent blog post considers how to best collect data during the COVID-19 pandemic. Baltezegar writes [...]
Xcenda Blog: Mind the (Evidence) Gap
Xcenda in a blog post considers how drug manufacturers can gather evidence to develop their value story before and after [...]
Aetion, HealthVerity Launch RWE System
Aetion and HealthVerity last month launched a new real-world evidence system aimed at helping the assessment of treatment approaches for [...]
Article Highlights FDA Decisions that Involved RWE
A recent article published on Aetion looks at three recent decisions by the Food and Drug Administration (FDA) that included [...]
Veradigm Platform Generates Actionable RWE
Veradigm in a recent analysis found that de-identified data from its EHR platform could be used to generate "actionable and [...]
Can Medtech Use Social Media to Generate RWE?
GP and digital RWE advisor Simon Rudland and Orbital Research CEO Peter Brady in a recent interview with Med-Tech Innovation [...]
